K. Laut

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression

A. Mocroft, R. Paredes, H. Stellbrink, 2016, Medicine.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

A. Mocroft, O. Kirk, J. Lundgren, 2018, AIDS.

Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015

A. Mocroft, O. Kirk, A. Blaxhult, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey

A. Mocroft, J. Lazarus, M. Johnson, 2016, BMC Infectious Diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

The EuroSIDA study: 25 years of scientific achievements

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, HIV medicine.

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

C. Leen, A. Mocroft, J. Gatell, 2018, AIDS.

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

A. Mocroft, A. d’Arminio Monforte, A. Clarke, 2018, HIV medicine.

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

A. Mocroft, J. Gatell, P. Reiss, 2017, AIDS.

Associations between HIV-RNA-based indicators and virological and clinical outcomes

A. Mocroft, O. Kirk, J. Lundgren, 2016, AIDS.